Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology
暂无分享,去创建一个
[1] Max Theiler,et al. THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION , 1937, The Journal of experimental medicine.
[2] A. Barrett,et al. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? , 2009, Current opinion in immunology.
[3] A. Prata. Yellow fever. , 2000, Memorias do Instituto Oswaldo Cruz.
[4] M. Cetron,et al. Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. , 2008, The Journal of infectious diseases.
[5] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[6] N. Sonenberg,et al. Regulation of cap-dependent translation by eIF4E inhibitory proteins , 2005, Nature.
[7] B. Pulendran,et al. Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease , 2007, Vaccine.
[8] E. Hindle,et al. A YELLOW FEVER VACCINE , 1928, British medical journal.
[9] Robert T. Chen,et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. , 2005, Vaccine.
[10] A. Barrett,et al. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. , 1997, Virology.
[11] Osamu Takeuchi,et al. Innate immunity to virus infection , 2009, Immunological reviews.
[12] Eva K. Lee,et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans , 2009, Nature Immunology.
[13] A. Rothman,et al. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. , 2002, Virology.
[14] A. Keating,et al. Functional properties and genomics of glucose transporters. , 2007, Current genomics.
[15] R. Kaufman. coordination of gene transcriptional and translational controls Stress signaling from the lumen of the endoplasmic reticulum , 2008 .
[16] R. Woodland,et al. BLyS and B cell homeostasis. , 2006, Seminars in immunology.
[17] A. Sabin. Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.
[18] Bali Pulendran,et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity , 2006, The Journal of experimental medicine.
[19] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Teixeira-Carvalho,et al. Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination. , 2008, Vaccine.
[21] T. Mizutani,et al. Different chemokine expression in lethal and non‐lethal murine west nile virus infection , 2004, Journal of medical virology.
[22] A. Luster,et al. Dengue Virus Induces Expression of CXC Chemokine Ligand 10/IFN-γ-Inducible Protein 10, Which Competitively Inhibits Viral Binding to Cell Surface Heparan Sulfate1 , 2006, The Journal of Immunology.
[23] Á. L. Bertho,et al. Detection of Th1/Th2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay. , 2008, Cytokine.
[24] Ken Draper,et al. Single Mutation in the Flavivirus Envelope Protein Hinge Region Increases Neurovirulence for Mice and Monkeys but Decreases Viscerotropism for Monkeys: Relevance to Development and Safety Testing of Live, Attenuated Vaccines , 2002, Journal of Virology.
[25] J. Altman,et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.
[26] B. Pulendran. Variegation of the Immune Response with Dendritic Cells and Pathogen Recognition Receptors1 , 2005, The Journal of Immunology.
[27] Bastian R. Angermann,et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses , 2008, The Journal of experimental medicine.
[28] P. Anderson,et al. Mammalian stress granules and processing bodies. , 2007, Methods in enzymology.
[29] Virginia Pascual,et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.
[30] H. Dressman,et al. Genomic signatures to guide the use of chemotherapeutics , 2006, Nature Medicine.
[31] B. Pulendran,et al. Toll-like receptor–mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway , 2008, Nature Immunology.
[32] K. Popper,et al. Conjectures and Refutations , 1963 .
[33] F. Guirakhoo,et al. Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. , 2001, Virology.
[34] Matthias Niedrig,et al. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infection , 1998, Journal of medical virology.
[35] R. Steinman,et al. Taking dendritic cells into medicine , 2007, Nature.
[36] D. Teuwen,et al. Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. , 2008, The Journal of infectious diseases.
[37] D. Sabatini,et al. Growing roles for the mTOR pathway. , 2005, Current opinion in cell biology.
[38] S. Akira,et al. The RNA Helicase Lgp2 Inhibits TLR-Independent Sensing of Viral Replication by Retinoic Acid-Inducible Gene-I1 , 2005, The Journal of Immunology.
[39] P. Walter,et al. Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.
[40] J. H. Strauss,et al. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[41] Hugh H. Smith,et al. THE EFFECT OF PROLONGED CULTIVATION IN VITRO UPON THE PATHOGENICITY OF YELLOW FEVER VIRUS , 1937, The Journal of experimental medicine.
[42] J. Banchereau,et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. , 2007, Blood.
[43] F. Guirakhoo,et al. A Single Amino Acid Substitution in the Envelope Protein of Chimeric Yellow Fever-Dengue 1 Vaccine Virus Reduces Neurovirulence for Suckling Mice and Viremia/Viscerotropism for Monkeys , 2004, Journal of Virology.
[44] N. Sonenberg,et al. Antiviral effect of the mammalian translation initiation factor 2α kinase GCN2 against RNA viruses , 2006, The EMBO journal.
[45] Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain. , 1996, The Journal of general virology.
[46] S. Fernandez,et al. Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells. , 2007, The Journal of general virology.
[47] B. Dixon. Microbe Hunters—Then and Now , 1996 .
[48] C. Rice,et al. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes , 2005, The Journal of experimental medicine.